Investors Research Corp Buys 2,800 Shares of Danaher Corporation $DHR

Investors Research Corp lifted its position in Danaher Corporation (NYSE:DHR) by 28,000.0% during the 2nd quarter, Holdings Channel reports. The firm owned 2,810 shares of the conglomerate’s stock after acquiring an additional 2,800 shares during the period. Investors Research Corp’s holdings in Danaher were worth $535,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. High Note Wealth LLC grew its holdings in Danaher by 19.2% in the 4th quarter. High Note Wealth LLC now owns 292 shares of the conglomerate’s stock worth $67,000 after acquiring an additional 47 shares during the last quarter. First Command Advisory Services Inc. increased its position in shares of Danaher by 4.4% in the fourth quarter. First Command Advisory Services Inc. now owns 1,104 shares of the conglomerate’s stock valued at $253,000 after acquiring an additional 47 shares during the period. GW&K Investment Management LLC raised its stake in shares of Danaher by 8.4% during the fourth quarter. GW&K Investment Management LLC now owns 605 shares of the conglomerate’s stock valued at $138,000 after acquiring an additional 47 shares during the last quarter. Kestra Private Wealth Services LLC raised its stake in shares of Danaher by 0.3% during the third quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate’s stock valued at $3,057,000 after acquiring an additional 48 shares during the last quarter. Finally, Gabelli Funds LLC boosted its holdings in shares of Danaher by 0.3% during the fourth quarter. Gabelli Funds LLC now owns 18,981 shares of the conglomerate’s stock worth $4,345,000 after purchasing an additional 50 shares during the period. 79.05% of the stock is currently owned by institutional investors.

Danaher Price Performance

DHR stock opened at $210.07 on Thursday. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The company has a market cap of $147.68 billion, a P/E ratio of 37.31, a PEG ratio of 2.58 and a beta of 0.78. The firm has a 50-day moving average of $201.15 and a 200 day moving average of $192.19. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating the consensus estimate of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The business had revenue of $6.26 billion for the quarter, compared to analysts’ expectations of $6.12 billion. During the same period in the previous year, the firm posted $0.77 EPS. The business’s revenue was up 5.5% on a year-over-year basis. On average, sell-side analysts forecast that Danaher Corporation will post 8.53 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on DHR. HSBC cut their target price on Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a research note on Wednesday, June 3rd. Weiss Ratings raised Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, July 15th. Citigroup began coverage on Danaher in a report on Tuesday, May 26th. They issued a “buy” rating and a $230.00 price objective for the company. Evercore reiterated an “outperform” rating and issued a $230.00 price objective on shares of Danaher in a research report on Monday, July 6th. Finally, Wells Fargo & Company reduced their target price on Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research note on Wednesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, Danaher presently has an average rating of “Moderate Buy” and an average price target of $228.91.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.